Presentations by David Taber

• Mon-04 from 12:15 - 15:15 in room 4
  Beyond Just Survival: Addressing Transplant Recipients’ Perspective of Unmet Immunosuppressant Needs: The AST’s National Survey of 10,000 Transplant Recipients
  Survey Rationale, Design, and High-Level Findings
• Sun-03 from 16:30 - 17:45 in room 4
  Cytomegalovirus: Antivirals and Immune Defense
  6-Month Outcomes of a Randomized Controlled Trial Comparing the Tolerability and Efficacy of Maribavir vs. Valganciclovir for CMV Prophylaxis in High-Risk Kidney Transplant Recipients
• Sun-03 from 10:30 - 11:30 in room Plenary
  Plenary Abstracts 1
  Burdens of Therapy: AST’s National Patient Survey of Unmet Immunosuppressant Needs